These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3184522)

  • 1. [Effect of ursodeoxycholic acid (UDCA) treatment on nucleation time (NT)].
    Tazuma S; Sasaki H; Mizuno S; Nomura Y; Horiuchi I; Kajiyama G; Nakai S; Kado S; Masuda T
    Nihon Shokakibyo Gakkai Zasshi; 1988 Aug; 85(8):1530-5. PubMed ID: 3184522
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nucleation time and growth time in patients with cholesterol gallstone--factors affecting nucleation time and growth time and effect of UDCA and CDCA].
    Nomura Y
    Nihon Shokakibyo Gakkai Zasshi; 1989 May; 86(5):1103-13. PubMed ID: 2795947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism.
    Tint GS; Salen G; Shefer S
    Gastroenterology; 1986 Oct; 91(4):1007-18. PubMed ID: 3527851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ursodeoxycholic acid (UDCA) in the treatment of cholesterol cholelithiasis of the gallbladder and bile ducts].
    Goszcz A
    Pol Tyg Lek; 1983 Feb; 38(7):221-4. PubMed ID: 6346288
    [No Abstract]   [Full Text] [Related]  

  • 5. Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. part I.
    Bachrach WH; Hofmann AF
    Dig Dis Sci; 1982 Aug; 27(8):737-61. PubMed ID: 7094795
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones.
    Jüngst D; Brenner G; Pratschke E; Paumgartner G
    J Hepatol; 1989 Jan; 8(1):1-6. PubMed ID: 2921499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The medical treatment of cholesterol gallstones. A major advance in preventive gastroenterology.
    Hofmann AF
    Am J Med; 1980 Jul; 69(1):4-7. PubMed ID: 7386506
    [No Abstract]   [Full Text] [Related]  

  • 8. [New therapeutic methods--technics, application, efficacy and problems. Litholysis. a) Theory of litholysis and development of litholytic agents].
    Makino I; Yoneda M; Tamasawa N; Takebe K
    Nihon Rinsho; 1987 Jul; 45(7):1539-46. PubMed ID: 3669350
    [No Abstract]   [Full Text] [Related]  

  • 9. [Endoscopic treatments. Etiopathogenesis and medical treatment of cholesterol lithiasis].
    Pirotte J
    Rev Med Liege; 1988 May; 43(9):365-9. PubMed ID: 3291050
    [No Abstract]   [Full Text] [Related]  

  • 10. Gallstone dissolution and the cholesterol--bile acid--lipoprotein axis. Propitious effects of ursodeoxycholic acid.
    Fromm H
    Gastroenterology; 1984 Jul; 87(1):229-33. PubMed ID: 6724267
    [No Abstract]   [Full Text] [Related]  

  • 11. Gallstone dissolution after 6 months of ursodeoxycholic acid (UDCA): effectiveness of different doses.
    Podda M; Zuin M; Carulli N; Ponz de Leon M; Dioguardi ML
    J Int Med Res; 1982; 10(1):59-63. PubMed ID: 7060825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical dissolution of gallstones.
    JAMA; 1983 Nov; 250(17):2373-4. PubMed ID: 6355529
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in serum bile acids during treatment with chenodiol or ursodiol for dissolution of cholesterol gallstones.
    Nowak M; Panveliwalla D; Pertsemlidis D
    Mt Sinai J Med; 1983; 50(3):240-4. PubMed ID: 6604868
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the purified unsaponifiable fraction of soybean in combination with ursodeoxycholic acid on cholesterol saturation of bile and stone dissolution in gallstone patients.
    Kajiyama G; Kawamoto T; Fujiyama M; Maruhashi A; Miyoshi A
    Hiroshima J Med Sci; 1981 Jun; 30(2):71-83. PubMed ID: 7028684
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of ursodeoxycholic acid administration on biliary lipid composition and bile acid kinetics in cholesterol gallstone patients.
    Roda E; Roda A; Sama C; Festi D; Mazzella G; Aldini R; Barbara L
    Dig Dis Sci; 1979 Feb; 24(2):123-8. PubMed ID: 428300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part II.
    Bachrach WH; Hofmann AF
    Dig Dis Sci; 1982 Sep; 27(9):833-56. PubMed ID: 7049627
    [No Abstract]   [Full Text] [Related]  

  • 19. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
    Nilsell K
    Acta Chir Scand Suppl; 1985; 528():1-38. PubMed ID: 3866449
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of response to ursodeoxycholic acid for gallstone dissolution.
    Bateson MC; Hill A; Bouchier IA
    Digestion; 1980; 20(5):358-64. PubMed ID: 7390061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.